Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05701930
Other study ID # 2022/ 16- 14
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 18, 2023
Est. completion date February 25, 2024

Study information

Verified date January 2024
Source Ataturk University
Contact Gülcan B.TURAN, PHD
Phone 05065576086
Email glcnbah@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cancer; It is defined as a large group of diseases that can start in any organ or tissue of the body, occur with the uncontrolled growth of abnormal cells, and occur when these abnormal cells go beyond their normal limits and spread to neighboring tissues and other organs. The leading goal of cancer treatment is to eradicate the cancer. Cancer treatments are divided into two basic groups as local and systemic.Systemic treatments include chemotherapy, hormone therapy, targeted molecular therapy, and immunotherapy. The use of drugs that slow down, control, stop and destroy cancer cells in the treatment are called chemotherapy, and the drugs used for this purpose are called chemotherapeutics (cytostatics) or antineoplastic drugs. Quality of life is personal well-being and is an expression of subjective satisfaction in different areas of life. This concept includes family, work life and socio-economic conditions. It includes the difference between the ideals, expectations and dreams of individuals and the reality, that is, the perception of satisfaction and well-being that the individual receives from his daily life. In the medical field, it is the expression of the individual's physical, emotional and social well-being. The symptoms that cancer patients encounter both in cancer and in the treatment process affect the quality of life of the patient and cause the treatment to be interrupted. Therefore, symptom management is very important in order not to hinder treatment and to stop the risk of morbidity and mortality. Most of the symptoms of advanced cancer patients can be managed with pharmacological or non-pharmacological methods, and this management is an expected skill for all clinicians who take care of patients with cancer. Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and there is little text on the slides.


Description:

The patients in the experimental group will be trained by the pecha kucha method using a computer with powepoint presentation. Those in the control group will be trained with classical lessons. The training content will be composed of information that will help in the diagnosis and management of symptoms of cancer patients and increase their quality of life. Symptom diagnosis and quality of life scales will be used as data collection tools in education. All patients in the groups will be trained without changing the content of the training. Only the training method will be different. Data will be collected from cancer patients in both experimental and control groups before, immediately after, and 3 months after training. Both face-to-face theoretical explanation and question-answer method will be used as training techniques for the control group. Pecha kucha presentation will be used as a training technique for the experimental group. The training will be prepared in visual density and minimal text in accordance with the pecha kucha technique and will be composed of 20 slides with a powerpoint presentation. The presentation will last 6 minutes and 40 seconds. After the training, a feedback and question-answer session will be held for both the experimental and control groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date February 25, 2024
Est. primary completion date May 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Being 18 years or older, - Not having a verbal communication disability (hearing and speaking), - Being a Cancer Patient in the second or third stage Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
symptom management
pecha kucha training

Locations

Country Name City State
Turkey Gülcan B.Turan Elazig Merkez

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Edmonton Symptom Diagnostic Scale It was developed to evaluate nine symptoms seen in cancer patients. The scale includes pain, fatigue, nausea, sadness, anxiety, insomnia, loss of appetite, well-being and
shortness of breath. In scale; The severity of each symptom is evaluated with numerical scores from 0 to 10. The most important rule in the evaluation of the symptom is to mark the number indicating the severity of the symptom according to the patient's own expression. The patient is asked to match the symptoms he or she is experiencing with a number from 0 to 10 that he thinks is most suitable for him. A score of 0 in the scale indicates the absence of symptoms, while a score of 10 indicates that the symptom is experienced very severely.
1 hours
Primary EORTC QLQ-C 30 Quality of Life Scale This scale was developed by the European cancer treatment and research organization in 1987 to evaluate the quality of life of patients with cancer. 1 hours
See also
  Status Clinical Trial Phase
Completed NCT05635578 - The Effect of Reiki Applicatıon on Sleep and Qualıty of Life in Epılepsy Patıents N/A
Completed NCT06290700 - Effect of Neonatal Care Education for Primiparous Pregnant Women on Postpartum Maternal Function and Quality of Life N/A
Completed NCT06436872 - The Effect of Informing the Relatives of Patients Undergoing Open Heart Surgery N/A
Active, not recruiting NCT05726552 - Effect of Laughter Therapy on hemodıalysıs patıents N/A
Completed NCT03492320 - Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
Enrolling by invitation NCT05951803 - Effectiveness of a Psychological Intervention on Mental Health and Sleep. N/A
Not yet recruiting NCT05420987 - Effect of Jing Si Herbal Tea on Inflammation in Patients With Cardiovascular Disease N/A
Completed NCT04274556 - Recovery Time and Affecting Factors in Hemodialysis Patients
Completed NCT05402592 - The Effect of Oral Carbohydrate Administration on Postoperative Well-being N/A
Recruiting NCT05682573 - Study on Immune Status of Patients With COVID-19
Recruiting NCT06116812 - The Effect of Laughter and Mindfulness Therapy Applications on Women With Breast Cancer Receiving Chemotherapy: Randomized Controlled Study N/A
Completed NCT04838470 - Prognosis Predictors for Heart Failure
Not yet recruiting NCT05781971 - Effect of Nutritional Support and Early Rehabilitation on Sepsis N/A
Completed NCT03991689 - The Effect of Solution-focused Group Therapy for Pain Management in Patients With Spinal Cord Injury N/A
Not yet recruiting NCT05933122 - Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention N/A
Not yet recruiting NCT06333574 - Weight Management of Dialysis Patients N/A